8 results
S-3
EX-1.2
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
shall be made in accordance with terms agreed upon between such Agent and the Company as evidenced by a Terms Agreement. The applicable Agent’s commitment
8-K
EX-10.1
MLYS
Mineralys Therapeutics Inc
8 Feb 24
Mineralys Therapeutics Announces $120 Million Private Placement Financing
4:41pm
, extend or enter into any such option, warrant, call, subscription or other
right, agreement, arrangement or commitment. Neither the execution
DRS/A
MLYS
Mineralys Therapeutics Inc
29 Dec 22
Draft registration statement (amended)
12:00am
and guidance beginning as early as Phase 1 and an organizational commitment to expedite the development and review of the product candidate, including
DRS/A
MLYS
Mineralys Therapeutics Inc
7 Dec 22
Draft registration statement (amended)
12:00am
and an organizational commitment to expedite the development and review of the product candidate, including involvement of senior managers.
Any product candidate
DRS
nwp57772dr13d4
4 Nov 22
Draft registration statement
12:00am
DRS
EX-10.9
h4qwok29uee yvela6
4 Nov 22
Draft registration statement
12:00am
DRS
EX-3.1
fiqyhrgzg 3ork2
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next